Agrin and low-density lipoprotein–related receptor protein 4 antibodies in amyotrophic lateral sclerosis patients

Michael H. Rivner, Siyang Liu, Brandy Quarles, Brandi Fleenor, Chengyong Shen, Jinxiu Pan, Lin Mei

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Introduction: The prevalence and characteristics of agrin and low-density lipoprotein–related receptor protein 4 (LRP4) antibody-positive amyotrophic lateral sclerosis (ALS) patients were studied. Methods: We tested 82 ALS patients and 59 controls for agrin and LRP4 antibodies using enzyme-linked immunoassay (ELISA). Results: We found that 13.8% of ALS patients had agrin antibodies, and 9.8% had LRP4 antibodies. Women with ALS are twice as likely as men to have antibodies. Agrin-positive ALS patients are younger than agrin-negative ALS patients. Conclusions: Antibodies to agrin and LRP4 are found in ALS patients. It must be determined whether these antibodies are pathogenic. Because antibody-positive patients have upper as well as lower motor neuron findings, the antibodies' effects cannot be explained solely by their actions at the neuromuscular junction. A breakdown in interneuronal signaling may be the cause of ALS. Further research is needed to resolve this question. Muscle Nerve, 2016 Muscle Nerve 55: 430–432, 2017.

Original languageEnglish (US)
Pages (from-to)430-432
Number of pages3
JournalMuscle and Nerve
Volume55
Issue number3
DOIs
StatePublished - Mar 1 2017

Fingerprint

Agrin
Amyotrophic Lateral Sclerosis
Antibodies
Proteins
Muscles
Neuromuscular Junction
Motor Neurons
Immunoenzyme Techniques

Keywords

  • ALS
  • Agrin
  • LRP4
  • amyotrophic lateral sclerosis
  • antibodies
  • low-density lipoprotein–related receptor protein 4

ASJC Scopus subject areas

  • Physiology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)

Cite this

Agrin and low-density lipoprotein–related receptor protein 4 antibodies in amyotrophic lateral sclerosis patients. / Rivner, Michael H.; Liu, Siyang; Quarles, Brandy; Fleenor, Brandi; Shen, Chengyong; Pan, Jinxiu; Mei, Lin.

In: Muscle and Nerve, Vol. 55, No. 3, 01.03.2017, p. 430-432.

Research output: Contribution to journalArticle

Rivner, Michael H. ; Liu, Siyang ; Quarles, Brandy ; Fleenor, Brandi ; Shen, Chengyong ; Pan, Jinxiu ; Mei, Lin. / Agrin and low-density lipoprotein–related receptor protein 4 antibodies in amyotrophic lateral sclerosis patients. In: Muscle and Nerve. 2017 ; Vol. 55, No. 3. pp. 430-432.
@article{c9c6404a77734be0b52fef97c4d90106,
title = "Agrin and low-density lipoprotein–related receptor protein 4 antibodies in amyotrophic lateral sclerosis patients",
abstract = "Introduction: The prevalence and characteristics of agrin and low-density lipoprotein–related receptor protein 4 (LRP4) antibody-positive amyotrophic lateral sclerosis (ALS) patients were studied. Methods: We tested 82 ALS patients and 59 controls for agrin and LRP4 antibodies using enzyme-linked immunoassay (ELISA). Results: We found that 13.8{\%} of ALS patients had agrin antibodies, and 9.8{\%} had LRP4 antibodies. Women with ALS are twice as likely as men to have antibodies. Agrin-positive ALS patients are younger than agrin-negative ALS patients. Conclusions: Antibodies to agrin and LRP4 are found in ALS patients. It must be determined whether these antibodies are pathogenic. Because antibody-positive patients have upper as well as lower motor neuron findings, the antibodies' effects cannot be explained solely by their actions at the neuromuscular junction. A breakdown in interneuronal signaling may be the cause of ALS. Further research is needed to resolve this question. Muscle Nerve, 2016 Muscle Nerve 55: 430–432, 2017.",
keywords = "ALS, Agrin, LRP4, amyotrophic lateral sclerosis, antibodies, low-density lipoprotein–related receptor protein 4",
author = "Rivner, {Michael H.} and Siyang Liu and Brandy Quarles and Brandi Fleenor and Chengyong Shen and Jinxiu Pan and Lin Mei",
year = "2017",
month = "3",
day = "1",
doi = "10.1002/mus.25438",
language = "English (US)",
volume = "55",
pages = "430--432",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Agrin and low-density lipoprotein–related receptor protein 4 antibodies in amyotrophic lateral sclerosis patients

AU - Rivner, Michael H.

AU - Liu, Siyang

AU - Quarles, Brandy

AU - Fleenor, Brandi

AU - Shen, Chengyong

AU - Pan, Jinxiu

AU - Mei, Lin

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Introduction: The prevalence and characteristics of agrin and low-density lipoprotein–related receptor protein 4 (LRP4) antibody-positive amyotrophic lateral sclerosis (ALS) patients were studied. Methods: We tested 82 ALS patients and 59 controls for agrin and LRP4 antibodies using enzyme-linked immunoassay (ELISA). Results: We found that 13.8% of ALS patients had agrin antibodies, and 9.8% had LRP4 antibodies. Women with ALS are twice as likely as men to have antibodies. Agrin-positive ALS patients are younger than agrin-negative ALS patients. Conclusions: Antibodies to agrin and LRP4 are found in ALS patients. It must be determined whether these antibodies are pathogenic. Because antibody-positive patients have upper as well as lower motor neuron findings, the antibodies' effects cannot be explained solely by their actions at the neuromuscular junction. A breakdown in interneuronal signaling may be the cause of ALS. Further research is needed to resolve this question. Muscle Nerve, 2016 Muscle Nerve 55: 430–432, 2017.

AB - Introduction: The prevalence and characteristics of agrin and low-density lipoprotein–related receptor protein 4 (LRP4) antibody-positive amyotrophic lateral sclerosis (ALS) patients were studied. Methods: We tested 82 ALS patients and 59 controls for agrin and LRP4 antibodies using enzyme-linked immunoassay (ELISA). Results: We found that 13.8% of ALS patients had agrin antibodies, and 9.8% had LRP4 antibodies. Women with ALS are twice as likely as men to have antibodies. Agrin-positive ALS patients are younger than agrin-negative ALS patients. Conclusions: Antibodies to agrin and LRP4 are found in ALS patients. It must be determined whether these antibodies are pathogenic. Because antibody-positive patients have upper as well as lower motor neuron findings, the antibodies' effects cannot be explained solely by their actions at the neuromuscular junction. A breakdown in interneuronal signaling may be the cause of ALS. Further research is needed to resolve this question. Muscle Nerve, 2016 Muscle Nerve 55: 430–432, 2017.

KW - ALS

KW - Agrin

KW - LRP4

KW - amyotrophic lateral sclerosis

KW - antibodies

KW - low-density lipoprotein–related receptor protein 4

UR - http://www.scopus.com/inward/record.url?scp=85006272605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006272605&partnerID=8YFLogxK

U2 - 10.1002/mus.25438

DO - 10.1002/mus.25438

M3 - Article

C2 - 27756107

AN - SCOPUS:85006272605

VL - 55

SP - 430

EP - 432

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

IS - 3

ER -